Phytochemicals as an adjuvant in leukemia therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.

  2016cited by this paper
• Symptoms of adult chronic and acute leukaemia before diagnosis: large primary care case-control studies using electronic records.

  2016cited by this paper
• Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species

  2016cited by this paper
• Curcumin Boosts up the Efficacy of Imatinib Mesylate in Chronic Myelogenic Leukemia Cell Line K-562 by Modulation of Various Markers

  2016cited by this paper
• Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

  2016influential reference
• Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.

  2016cited by this paper
• Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB.

  2016cited by this paper
• Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances

  2015cited by this paper
• Genes and childhood leukemia.

  2015cited by this paper
• Interactions Between Nutraceutical Supplements and Standard Acute Myeloid Leukemia Chemotherapeutics.

  2015cited by this paper
• Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells.

  2015cited by this paper
• Anti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants

  2015cited by this paper
• Synergistic Apoptotic Effect Of Indole-3-Carbinol And Doxorubicin On Pre-B Acute Lymphoblastic Leukemia Cells

  2015cited by this paper
• Development and characterization of lidocaine transdermal system with Self-Emulsifying Nanosystem (SENs)

  2015cited by this paper
• Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.

  2015cited by this paper
• The anti-leukemic effect of carnosic acid combined with adriamycin in a K562/A02/SCID leukemia mouse model.

  2015cited by this paper
• Nitric oxide is the key mediator of death induced by fisetin in human acute monocytic leukemia cells.

  2015cited by this paper
• Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity

  2014cited by this paper
• Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors

  2014cited by this paper
• Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia

  2014cited by this paper
• Genistein decreases cellular redox potential, partially suppresses cell growth in HL-60 leukemia cells and sensitizes cells to γ-radiation-induced cell death

  2014cited by this paper
• Sex differences in the incidence of chronic myeloid leukemia

  2014cited by this paper
• Treatment Recommendations for Chronic Myeloid Leukemia

  2014cited by this paper
• Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway

  2014cited by this paper
• Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials

  2014cited by this paper
• Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go

  2014cited by this paper
• Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6.

  2014cited by this paper
• Glycyrrhetinic Acid Induces Apoptosis in Leukemic HL60 Cells Through Upregulating of CD95/ CD178

  2014cited by this paper
• Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.

  2013cited by this paper
• Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma

  2013cited by this paper
• Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia

  2013cited by this paper
• Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment

  2013cited by this paper
• Acute lymphoblastic leukaemia.

  2013cited by this paper
• OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.

  2013cited by this paper
• Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737

  2013cited by this paper
• Genetic predispositions to childhood leukemia

  2013cited by this paper
• Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans

  2013cited by this paper
• Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.

  2013cited by this paper
• Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function.

  2012cited by this paper
• Survival for older patients with acute myeloid leukemia: a population-based study

  2012cited by this paper
• Crocetin: an agent derived from saffron for prevention and therapy for cancer.

  2012cited by this paper
• Acute Leukemia in Children with Down Syndrome

  2012cited by this paper
• Chemotherapy and Dietary Phytochemical Agents

  2012cited by this paper
• Chronic Lymphocytic Leukemia in Young (≤ 55 years) Patients: A Comprehensive Analysis of Prognostic Factors and Outcomes.

  2012cited by this paper
• Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia

  2012cited by this paper
• The role of cytokines in acute myeloid leukemia: a systematic review.

  2012cited by this paper
• Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence.

  2012cited by this paper
• Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1

  2011cited by this paper
• Myeloid sarcoma: current approach and therapeutic options

  2011cited by this paper
• Genetic abnormalities and challenges in the treatment of acute myeloid leukemia.

  2011influential reference
• Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.

  2010cited by this paper
• Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors

  2010cited by this paper
• Leukaemogenesis: more than mutant genes

  2010influential reference
• Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

  2010cited by this paper
• Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia

  2009cited by this paper
• Treatment of Osteoporosis/Osteopenia in Pediatric Leukemia and Lymphoma

  2009cited by this paper
• Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues

  2009cited by this paper
• Overweight and obesity and incidence of leukemia: A meta‐analysis of cohort studies

  2008cited by this paper
• Treatment of pediatric acute lymphoblastic leukemia

  2008cited by this paper
• Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells.

  2008cited by this paper
• Role of the RUNX1‐EVI1 fusion gene in leukemogenesis

  2008cited by this paper
• Identification of new markers discriminating between myeloid and lymphoid acute leukemia

  2008cited by this paper
• Vitamin E and N-Acetylcysteine as Antioxidant Adjuvant Therapy in Children with Acute Lymphoblastic Leukemia

  2007cited by this paper
• Autocrine VEGF loops, signaling pathways, and acute leukemia regulation

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• Environmental and Occupational Causes of Cancer

  2007cited by this paper
• Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia

  2006cited by this paper
• Acute effects of radiation treatment: skin reactions.

  2006cited by this paper
• The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

  2003influential reference
• Molecular genetics in acute leukemia

  2000cited by this paper
• [Potentiated effects of total saponins of Panax Ginseng on inhibition of leukemic cells by cytotoxic drugs].

  1999cited by this paper
• Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden

  1993cited by this paper
• Mitoxantrone in the treatment of acute leukemia

  1987cited by this paper
• Chromosome abnormalities in leukemia and lymphoma.

  1983cited by this paper
• Chromosomal abnormalities in acute lymphoblastic leukemia.

  1981influential reference

• Essential oil components of Hydrocotyle verticillata leaf

  2024cites this paper
• Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL

  2023cites this paper
• Role of CD36 in cancer progression, stemness, and targeting

  2022cites this paper
• Partial Analysis Of Tlx 1 And Tlx 3 Genes In Adult And Children Patients Of Acute T-Cell Lymphblastic Leukemia

  2021cites this paper